Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

← catalyst calendar

NCT05160636 · readout in 165 d

Sponsored by Pfizer (industry) · PFE — their whole pipeline →. With CVS Caremark.

Phase
Status
Active, not recruiting
Study type
Observational
Enrollment
999estimated
Sites
1
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2022-01-31actualWhen the study began enrolling
Primary completion2027-01-31estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completion2027-01-31estimatedThe whole study's end, after follow-up
First posted2021-12-16actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-03-31actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • COVID-19
  • Coronavirus Disease 2019
  • Influenza

Intervention

  • Biological: COVID-19 Vaccine

Primary outcomes

what the primary-completion date above is the date OF
Change in Health Related Quality of Life (HRQoL) using EQ-5D-5L
measured 6 months
EQ-5D-5L Utility Index (UI) scores
measured 6 months
Visual Analog Scale (VAS) scores
measured 6 months
WPAI scores
measured 6 months

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed